Anesthesiology Doctors in Rocky Point, NY Accepting Medicare

25 Anesthesiology doctors found. Showing 21 - 25

Christine M Ruggiero, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 333 Route 25a Ste 225, Rocky Point, NY 11778 Phone: 631-744-3671

Sandy M Schachner, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 333 Route 25a, Ste 225, Rocky Point, NY 11778 Phone: 631-744-3671    Fax: 631-744-6205

Scott C Sherman, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 333 Route 25a, Ste 225, Rocky Point, NY 11778 Phone: 631-744-3671    Fax: 631-744-6205

Jeffrey C Rubenstein, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 333 Route 25a, Ste 225, Rocky Point, NY 11778 Phone: 631-744-3671    Fax: 631-744-6205

Anthony Matthew Frasca, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 333 Route 25a, Ste 225, Rocky Point, NY 11778 Phone: 631-744-3671    Fax: 631-744-6205

News Archive

Acal BFi inks channel partner agreement in Europe with SynQor

Acal BFi, European leader in advanced technology solutions, have signed a channel partner agreement in Europe with SynQor to include UK, Ireland, Denmark, Sweden, Norway, Finland, Belgium, Netherlands, Luxemburg and Italy.

Endosense releases TactiCath force-sensing ablation catheter

Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced the commercial release of its next generation TactiCath force-sensing ablation catheter. Recently granted CE mark and unveiled this month at the DGK 2010 - German Cardiac Society meeting in Mannheim, Germany, the second generation product includes an elegantly enhanced catheter along with a feature-rich supporting system called the TactiSys™.

Aradigm initiates dosing in Phase 2b trial of inhaled liposomal ciprofloxacin formulations in BE patients

Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.

New research shows people who feel lonely spread that feeling to others

Loneliness, like a bad cold, can spread among groups of people, research at the University of Chicago, the University of California-San Diego and Harvard shows.

Read more Medical News

› Verified 6 days ago

• 1
• 2(current)